CoStar Group (CSGP) › Analysis

CoStar Group (CSGP) stock analysis, November 3, 2026: Rebound inside a weekly downtrend, evidence evenly balanced

Published November 3, 2026 · CSGP chart, levels and live analysis

CoStar Group (CSGP) trades at about $31.24, having bounced from the $27.54 close that followed its October 27 earnings report. It is still 56% below its 52-week high and below its 40-week average. The weekly trend is down, and for the next two to six weeks the balance of evidence is even, with low conviction. A rebound against the trend is under way but not stretched, and sellers have shown up near $31.26 before.

Why it matters

The quarter was strong on the lines the company controls. Revenue rose 14% to $952 million, adjusted EBITDA hit a record $229 million, and management raised its 2026 adjusted EBITDA outlook to $820–840 million, with a $1.25 billion target for 2028, Seeking Alpha reported. The market looked past that. Revenue missed analyst estimates even though earnings per share beat, and the Vexcel acquisition added to the unease. The shares fell nearly 14% on October 28 to $27.54, according to Seeking Alpha.

The drop came after a run to a $35.45 close on October 22, so investors had paid up for a clean quarter and punished the first sign of a revenue shortfall. Since the low, the stock has recovered a good part of the loss. It is up about 14% over the past month but still 11.9% below that October peak.

Most of the last week's decline belongs to the market. CSGP fell 2.5% over five days against 2.06% for the S&P 500 ETF (SPY), so the stock lagged only slightly. No sector ETF figure is available for comparison. Today's 1.84% drop came while SPY rose 0.23%, and nothing in the news explains it. Volume is about 63% below its 20-day average, which suggests the move reflects little conviction.

The argument is about quality of growth and price. On the cautious side, Goldman Sachs cut its price target from $40 to $36, and a fair-value estimate was trimmed from $37.30 to $35.85 on execution risk, Yahoo Finance reported. A Seeking Alpha author points to weak residential profitability, high rates that weaken commercial real estate demand, and rich valuation multiples. The other side rests on the company's own numbers: record EBITDA, a raised outlook and a 2028 target that implies years of margin expansion. Twenty analysts rate the stock a buy on average. Their mean price target is $35.85, which is 12.9% above the current price, but targets range from $26 to $50. That spread shows how little agreement there is on what the business is worth, and the low end sits below the 52-week low of $26.95.

What the evidence says

The long-term thesis is badly weakened. The stock is down 53.6% year to date, 55.7% below its 52-week high of $70.44, below its 200-day average of $36.34 and below its 40-week average. It trails the S&P 500 by 17.9% over 200 days. The phase is a rebound inside a long downtrend: price has recovered above the 10-week average, but the larger trend has not turned.

For the next two to six weeks the evidence is even, and conviction is low, with none of four confirming points present. Two things keep the reading from leaning negative: a rally against the weekly downtrend that is not yet stretched (RSI 52.9), and a lead over the S&P 500 of 4.9% over 50 days. Neither is backed by the weekly trend, so neither can tip the balance toward the positive side.

The strongest case against an even reading is a negative one. Price sits just under $31.26, where sellers have appeared on earlier rallies. It is below the 200-day average and the 40-week average, and the 200-day relative performance is deeply negative. It does not tip the balance because the stock holds above its 50-day average at $30.29 and above the 10-week average, and RSI shows no pressure either way. Those facts are also why conviction is not higher in either direction.

Levels that matter

With the weekly trend down, the structure holds below $31.26, a zone where sellers have shown up on rallies. The price of $31.235 is right against it. The trend would end above $31.77, another swing zone, on a weekly close. Beyond that, resistance stacks up at $34.81, $35.00 and the 200-day average at $36.34.

The breakout level runs to the downside: a daily close below $30.29, the 50-day average, with $30.00 just beneath. From there the targets are $26.95, the 52-week low, at 2.3 to 1, and $26.60, a swing zone, at 2.6 to 1. The move would be wrong above a stop at $31.73, which is $31.26 plus a quarter of the 14-day average true range (ATR). The math does not reach the 3 to 1 that makes a breakout worth the risk. It would take a target further down, toward the $25 round-number level, to stretch the ratio past that.

What would change the picture

A weekly close above $31.77 would end the downtrend case and be the first sign that buyers have taken control. The non-price fact that would most likely produce it is a quarterly report in which revenue meets or beats estimates while the raised EBITDA path stays intact. A revenue miss was what turned the last report from a record quarter into a 14% drop.

What to watch

Get a message when the CSGP picture changes — the agent team watches the levels and the news for you.Create a free account

More CSGP analyses

Research & education, not advice. MarketCrew is AI-powered and can make mistakes.